Vascular dementia and parkinsonism

Nenhuma Miniatura disponível
Citações na Scopus
2
Tipo de produção
bookPart
Data de publicação
2014
DOI
Scopus
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER-VERLAG LONDON LTD
Autores
SILVEIRA-MORIYAMA, L.
CARAMELLI, P.
ZIJLMANS, J.
LEES, A. J.
Citação
Silveira-Moriyama, L.; Barbosa, E. R.; Caramelli, P.; Zijlmans, J.; Lees, A. J.. Vascular dementia and parkinsonism. In: . MOVEMENT DISORDERS IN DEMENTIAS, v.4: SPRINGER-VERLAG LONDON LTD, 2014. p.199-211.
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Cerebrovascular disease is a leading cause of mortality and morbidity worldwide. Its clinical manifestations vary from acute neurological defi cit to stepwise or slowly progressive chronic defi cits. Although originally described as separate entities, vascular dementia and vascular parkinsonism are overlapping spectrums of cognitive and extrapyramidal manifestations associated with subcortical vascular damage. In this chapter, we discuss the main concepts underlying the historical concepts of Binswanger encephalopathy and lowerbody parkinsonism, present the main features of vascular dementia and vascular parkinsonism, summarize recommendations for clinical management, and close with suggestions for future research in these prevalent and often neglected conditions. © 2014 Springer-Verlag London. All rights are reserved.
Palavras-chave
Binswanger encephalopathy, Cerebrovascular disease, Lower-body parkinsonism, Vascular dementia, Vascular parkinsonism
URI
https://observatorio.fm.usp.br/handle/OPI/51265
Referências
  1. Ballard, C.G., Burton, E.J., Barber, R., Stephens, S., Kenny, R.A., Kalaria, R.N., O'Brien, J.T., NINDS AIREN neuroimaging criteria do not distinguish stroke patients with and without dementia (2004) Neurology, 63 (6), pp. 983-988
  2. Ballard, C., Sauter, M., Scheltens, P., He, Y., Barkhof, F., Van Straaten, E.C., Van Der Flier, W.M., Lane, R., Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: The VantagE study (2008) Curr Med Res Opin, 24 (9), pp. 2561-2574
  3. Black, S., Román, G.C., Geldmacher, D.S., Salloway, S., Hecker, J., Burns, A., Perdomo, C., Pratt, R., Efficacy and tolerability of donepezil in vascular dementia: Positive results of a 24-week, multicenter, international, randomized, placebo- controlled clinical trial (2003) Stroke, 34 (10), pp. 2323-2330. , Donepezil 307 Vascular Dementia Study Group
  4. Bohnen, N.I., Muller, M.L., Zarzhevsky, N., Koeppe, R.A., Bogan, C.W., Kilbourn, M.R., Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease (2011) Brain, 134, pp. 2358-2365
  5. Bradley, W.G., Daroff, R.B., Fenichel, G., Jankovic, J., (2008) Neurology in Clinical Practice, , Philadelphia: Butterworth-Heinemann/Elsevier Saunders
  6. Brewster, P.W., Mcdowell, I., Moineddin, R., Tierney, M.C., Differential prediction of vascular dementia and Alzheimer's disease in nondemented older adults within 5 years of initial testing (2012) Alzheimers Dement, 8 (6), pp. 528-535
  7. Critchley, M., Arteriosclerotic parkinsonism (1929) Brain, 52, pp. 23-83
  8. Critchley, M., (1981) Arteriosclerotic Pseudo-parkinsonism, , Tunbridge Wells: Pitman Medical
  9. Demirkiran, M., Bozdemir, H., Sarica, Y., Vascular parkinsonism: A distinct, heterogeneous clinical entity (2001) Acta Neurol Scand, 104, pp. 63-67
  10. Erkinjuntti, T., Kurz, A., Gauthier, S., Bullock, R., Lilienfeld, S., Damaraju, C.V., Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: A randomized trial (2002) Lancet, 359, pp. 1283-1290
  11. Erkinjuntti, T., Roman, G., Gauthier, S., Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors (2004) J Neurol Sci, 226, pp. 63-66
  12. Fitzgerald, P.M., Jankovic, J., Lower body parkinsonism: Evidence for vascular etiology (1989) Mov Disord, 4, pp. 249-260
  13. Gibb, W.R., Lees, A.J., The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease (1988) J Neurol Neurosurg Psychiatry, 51, pp. 745-752
  14. Glass, P., (2012) Clinical Features of Vascular Parkinsonism in Pathologically ConfiRmed Cases, , MSc thesis, UCL Institute of Neurology. London
  15. Glass, P.G., Lees, A.J., Bacellar, A., Zijlmans, J., Katzenschlager, R., Silveira-Moriyama, L., The clinical features of pathologically confirmed vascular parkinsonism (2012) J Neurol Neurosurg Psychiatry, 83 (10), pp. 1027-1029
  16. Gorelick, P.B., Pantoni, L., Advances in vascular cognitive impairment (2013) Stroke, 44 (2), pp. 307-308
  17. Hachinski, V.C., Lassen, N.A., Multi-infarct dementia: A cause of mental deterioration in the elderly (1974) Lancet, 2, pp. 207-210
  18. Hachinski, V.C., Iliff, L.D., Zilhka, E., Cerebral blood flow in dementia (1975) Arch Neurol, 32, pp. 632-637
  19. Jellinger, K.A., Vascular parkinsonism-neuropathological findings (2002) Acta Neurol Scand, 105, pp. 414-415
  20. Kavirajan, H., Schneider, L.S., Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: A meta-analysis of randomized controlled trials (2007) Lancet Neurol, 6, pp. 782-792
  21. Katzenschlager, R., Zijlmans, J., Evans, A., Watt, H., Lees, A.J., Olfactory function distinguishes vascular parkinsonism from Parkinson's disease (2004) J Neurol Neurosurg Psychiatry, 75, pp. 1749-1752
  22. Mcshane, R., Areosa, A.S., Minakaran, N., Memantine for dementia (2011) Cochrane Database Syst Rev, (3), p. CD003154. , pub1
  23. McGuiness, B., Ohare, J., Craig, D., Statins for the treatment of dementia (2010) Cochrane Database Syst Rev, (8), p. CD007514
  24. Moroney, J.T., Bagiella, F., Desmond, D.W., Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias (1997) Neurology, 49, pp. 1096-1105
  25. Noyce, A.J., Bestwick, J.P., Silveira-Moriyama, L., Hawkes, C.H., Giovannoni, G., Lees, A.J., Schrag, A., Meta-analysis of early nonmotor features and risk factors for Parkinson disease (2012) Ann Neurol, 72 (6), pp. 893-901
  26. Pearce, J.M.S., Binswanger's encephalitis subcorticalis chronica progressiva (1997) J Neurol Neurosurg Psychiatry, 63, p. 308
  27. Peters, R., Beckett, N., Forette, F., Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): A double- blind, placebo controlled trial (2008) Lancet Neurol, 7, pp. 683-689
  28. Rampello, L., Alvano, A., Battaglia, G., Raffaele, R., Vecchio, I., Malaguarnera, M., Different clinical and evolutional patterns in late idiopathic and vascular parkinsonism (2005) J Neurol, 252, pp. 1045-1049
  29. Román, C.G., Tatemichi, T.K., Erkinjuntti, T., Vascular dementia: Diagnostic criteria for research studies (1993) Neurology, 43, pp. 250-260. , Report of the NINCDS-AIREN International Workshop
  30. Román, G.C., Facts, myths, and controversies in vascular dementia (2004) J Neurol Sci, 226 (1-2), pp. 49-52
  31. Sabbagh, M.N., Sparks, D.L., Statins to treat Alzheimer's disease: An incomplete story (2012) Expert Rev Neurother, 12 (1), pp. 27-30
  32. Santangelo, G., Vitale, C., Trojano, L., De Gaspari, D., Bilo, L., Antonini, A., Barone, P., Differential neuropsychological profiles in Parkinsonian patients with or without vascular lesions (2010) Mov Disord, 25, pp. 50-56
  33. Seitz, D.P., Adunuri, N., Gill, S.S., Gruneir, A., Herrmann, N., Rochon, P., Antidepressants for agitation and psychosis in dementia (2011) Cochrane Database Syst Rev, (2), p. CD008191
  34. Tang, W.K., Chan, S.S., Chiu, H.F., Ungvari, G.S., Wong, K.S., Kwok, T.C., Mok, V., Ahuja, A.T., Impact of applying NINDS-AIREN criteria of probable vascular dementia to clinical and radiological characteristics of a stroke cohort with dementia (2004) Cerebrovasc Dis, 18 (2), pp. 98-103
  35. Vale, T.C., Barbosa, M.T., Caramelli, P., Cardoso, F., Vascular parkinsonism and cognitive impairment (2012) Dement Neuropsychol, 6 (3), pp. 137-144
  36. Wilcock, G., Möbius, H.J., Stöffler, A., A double-blind, placebo-controlled, multicentre study of memantine in mild to moderate vascular dementia (MMM 500) (2002) Int Clin Psychopharmacol, 17, pp. 197-305. , MMM 500 group
  37. Winikates, J., Jankovic, J., Clinical correlates of vascular parkinsonism (1999) Arch Neurol, 56, pp. 98-102
  38. Witt, K., Borsch, K., Daniels, C., Neuropsychological consequences of endarterectomy and endovascular angioplasty with stent placement for treatment of symptomatic carotid stenosis, A prospective randomized study (2007) J Neurol, 254, pp. 1524-1532
  39. Zijlmans, J.C., Daniel, S.E., Hughes, A.J., Revesz, T., Lees, A.J., Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis (2004) Mov Disord, 19, pp. 630-640
  40. Zijlmans, J.C., Katzenschlager, R., Daniel, S.E., Lees, A.J., The L-dopa response in vascular parkinsonism (2004) J Neurol Neurosurg Psychiatry, 75, pp. 545-547
  41. Zijlmans, J., Evans, A., Fontes, F., [123I] FP-CIT spect study in vascular parkinsonism and Parkinson's disease (2007) Mov Disord, 22, pp. 1278-1285

Coleções
Livros e Capítulos de Livros - HC/ICHC
Livros e Capítulos de Livros - LIM/45
Livros e Capítulos de Livros - ODS/03